Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 39 results.
User Information
Export Records
  1. 1.   Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity
  2. Tocco, Graziella; Canton, Serena; Laus, Antonio; Caboni, Pierluigi; Le Grice, Stuart F J; Tramontano, Enzo; Esposito, Francesca
  3. Molecules (Basel, Switzerland). 2023, Sep 19; 28(18):
  1. 2.   HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence
  2. Zhao, Xue Zhi; Métifiot, Mathieu; Kiselev, Evgeny; Kessl, Jacques J; Maddali, Kasthuraiah; Marchand, Christophe; Kvaratskhelia, Mamuka; Pommier, Yves; Burke, Terrence
  3. Molecules . 2018, Aug; 23(8): pii: E1858.
  1. 3.   Localization of ASV Integrase-DNA Contacts by Site-Directed Crosslinking and their Structural Analysis
  2. Peletskaya, E.; Andrake, M.; Gustchina, A.; Merkel, G.; Alexandratos, J.; Zhou, D. W.; Bojja, R. S.; Satoh, T.; Potapov, M.; Kogon, A.; Potapov, V.; Wlodawer, A.; Skalka, A. M.
  3. Plos One. 2011, Dec; 6(12):
  1. 4.   Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)
  2. Hare, S.; Smith, S. J.; Metifiot, M.; Jaxa-Chamiec, A.; Pommier, Y.; Hughes, S. H.; Cherepanov, P.
  3. Molecular Pharmacology. 2011, Oct; 80(4): 565-572.
  1. 5.   Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression
  2. Madlala, P.; Gijsbers, R.; Christ, F.; Hombrouck, A.; Werner, L.; Mlisana, K.; An, P.; Karim, S. S. A.; Winkler, C. A.; Debyser, Z.; Ndung'u, T.
  3. Aids. 2011, Sep; 25(14): 1711-1719.
  1. 6.   Software and resources for computational medicinal chemistry
  2. Liao, C. Z.; Sitzmann, M.; Pugliese, A.; Nicklaus, M. C.
  3. Future Medicinal Chemistry. 2011, Jun; 3(8): 1057-1085.
  1. 7.   Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors
  2. Zhao, X. Z.; Maddali, K.; Metifiot, M.; Smith, S. J.; Vu, B. C.; March, C.; Hughes, S. H.; Pommier, Y.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, May; 21(10): 2986-2990.
  1. 8.   Tautomerism and Magnesium Chelation of HIV-1 Integrase Inhibitors: A Theoretical Study
  2. Liao, C. Z.; Nicklaus, M. C.
  3. Chemmedchem. 2010, Jul 5; 5(7): 1053-1066.
  1. 9.   Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis
  2. Cao, X. F.; Plasencia, C.; Kanzaki, A.; Yang, A.; Burke, T. R.; Neamati, N.
  3. Current Cancer Drug Targets. 2009 9(2): 189-201.
  1. 10.   Functional Analysis of N-Terminal Residues of Ty1 Integrase
  2. Moore, S. P.; Garfinkel, D. J.
  3. Journal of Virology. 2009 83(18): 9502-9511.
  1. 11.   Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality
  2. Zhao, X. Z.; Maddali, K.; March, C.; Pommier, Y.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2009 17(14): 5318-5324.
  1. 12.   Recent progress in antiretrovirals - lessons from resistance
  2. Adamson, C. S.; Freed, E. O.
  3. Drug Discovery Today. 2008 13(9-10): 424-432.
  1. 13.   Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H
  2. March, C.; Beutler, J. A.; Wamiru, A.; Budihas, S.; Mollmann, U.; Heinisch, L.; Mellors, J. W.; Le Grice, S. F.; Pommier, Y.
  3. Antimicrobial Agents and Chemotherapy. 2008 52(1): 361-364.
  1. 14.   Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA
  2. Liao, C. Z.; Karki, R. G.; March, C.; Pommier, Y.; Nicklaus, M. C.
  3. Bioorganic & Medicinal Chemistry Letters. 2007, Oct; 17(19): 5361-5365.
  1. 15.   Biotinylated biphenyl ketone-containing 2,4-dioxobutanoic acids designed as HIV-1 integrase photoaffinity ligands
  2. Zhao, X. Z.; Semenova, E. A.; Liao, C. Z.; Nicklaus, M.; Pommier, Y.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2006, Dec; 14(23): 7816-7825.
  1. 16.   Mining the NCI antiviral compounds for HIV-1 integrase inhibitors
  2. Deng, J. X.; Kelley, J. A.; Barchi, J. J.; Sanchez, T.; Dayam, R.; Pommier, Y.; Neamati, N.
  3. Bioorganic & Medicinal Chemistry. 2006, JUN 1; 14(11): 3785-3792.
  1. 17.   Retroviral DNA integration: reaction pathway and critical intermediates
  2. Li, M.; Mizuuchi, M.; Burke, T. R.; Craigie, R.
  3. Embo Journal. 2006, Mar; 25(6): 1295-1304.
  1. 18.   Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5 '-phosphate complex reveals a new binding site for a nucleotide inhibitor
  2. Williams, K. L.; Zhang, Y. J.; Shkriabai, N.; Karki, R. G.; Nicklaus, M. C.; Kotrikadze, N.; Hess, S.; Le Grice, S. F. J.; Craigie, R.; Pathak, V. K.; Kvaratskhelia, M.
  3. Journal of Biological Chemistry. 2005, MAR 4; 280(9): 7949-7955.
  1. 19.   Integrase of Mason-Pfizer monkey virus
  2. Snasel, J.; Krejcik, Z.; Jencova, V.; Rosenberg, I.; Ruml, T.; Alexandratos, J.; Gustchina, A.; Pichova, I.
  3. Febs Journal. 2005, JAN; 272(1): 203-216.
  1. 20.   Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design
  2. Karki, R. G.; Tang, Y.; Burke, T. R.; Nicklaus, M. C.
  3. Journal of Computer-Aided Molecular Design. 2004, DEC; 18(12): 739-760.
  1. 21.   Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin
  2. Krajewski, K.; March, C.; Long, Y. Q.; Pommier, Y.; Roller, P. P.
  3. Bioorganic & Medicinal Chemistry Letters. 2004, NOV 15; 14(22): 5595-5598.
  1. 22.   Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors
  2. Sechi, M.; Derudas, M.; Dallocchio, R.; Dessi, A.; Bacchi, A.; Sannia, L.; Carta, F.; Palomba, M.; Ragab, O.; Chan, C.; Shoemaker, R.; Sei, S.; Dayam, R.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5298-5310.
  1. 23.   Integration target site selection for retroviruses and transposable elements
  2. Wu, X.; Burgess, S. M.
  3. Cellular and Molecular Life Sciences. 2004, OCT; 61(19-20): 2588-2596.
  1. 24.   Caffeoyl-based affinity acetylators of HIV-1 integrase as novel pharmacological
  2. Patil, S. S.; Shkriabai, N.; Zhang, X. C.; Pais, G. C. G.; Svarovskaia, E. S.; Merch, C.; Pathak, V. K.; Pommier, Y.; Le Grice, S.; Kvaratskhelia, M.; Burke, T. R.
  3. Abstracts of Papers of the American Chemical Society. 2004, AUG 22; 228(Part 1): 329-MEDI, Abstract U967-329-MEDI, Abstract U967.
  1. 25.   Understanding the integrase inhibitory activity of azido containing HIV-1 integrase inhibitors
  2. Karki, R. G.; Nicklaus, M. C.
  3. Abstracts of Papers of the American Chemical Society. 2004, MAR 28; 227(017-MED, Part 2): U7-U7.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel